{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T12:19:26Z","timestamp":1775218766147,"version":"3.50.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T00:00:00Z","timestamp":1680048000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T00:00:00Z","timestamp":1680048000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1007\/s00277-023-05108-6","type":"journal-article","created":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T21:02:38Z","timestamp":1680123758000},"page":"1159-1169","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Systemic relapses of primary CNS lymphomas (PCNSL): a LOC network study"],"prefix":"10.1007","volume":"102","author":[{"given":"J.","family":"Dufour","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Choquet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Hoang-Xuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0877-2289","authenticated-orcid":false,"given":"G.","family":"Ahle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Houot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Taillandier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Gressin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Casasnovas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.P.","family":"Marolleau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Tamburini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Serrier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Perez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Paillassa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Gyan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Chauchet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Ursu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Kas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Soussain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Houillier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,3,29]]},"reference":[{"key":"5108_CR1","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/noy131","volume":"20","author":"QT Ostrom","year":"2018","unstructured":"Ostrom QT, Gittleman H, Truitt G et al (2018) CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2011\u20132015.\u00a0Neuro Oncol\u00a020:iv1\u2013iv86. https:\/\/doi.org\/10.1093\/neuonc\/noy131","journal-title":"Neuro-Oncology"},{"key":"5108_CR2","doi-asserted-by":"publisher","first-page":"5034","DOI":"10.1200\/JCO.2005.13.524","volume":"23","author":"LE Abrey","year":"2005","unstructured":"Abrey LE, Batchelor TT, Ferreri AJM et al (2005) Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma. J Clin Oncol 23:5034\u20135043. https:\/\/doi.org\/10.1200\/JCO.2005.13.524","journal-title":"J Clin Oncol"},{"key":"5108_CR3","doi-asserted-by":"publisher","first-page":"e322","DOI":"10.1016\/S1470-2045(15)00076-5","volume":"16","author":"K Hoang-Xuan","year":"2015","unstructured":"Hoang-Xuan K, Bessell E, Bromberg J et al (2015) Diagnosis and treatment of primary CNS lymphoma in immunocompetent patients: guidelines from the European Association for Neuro-Oncology. Lancet Oncol 16:e322\u2013e332. https:\/\/doi.org\/10.1016\/S1470-2045(15)00076-5","journal-title":"The Lancet Oncology"},{"key":"5108_CR4","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s11060-020-03525-5","volume":"148","author":"M Bertaux","year":"2020","unstructured":"Bertaux M, Houillier C, Edeline V et al (2020) Use of FDG-PET\/CT for systemic assessment of suspected primary central nervous system lymphoma: a LOC study. J Neurooncol 148:343\u2013352. https:\/\/doi.org\/10.1007\/s11060-020-03525-5","journal-title":"J Neurooncol"},{"key":"5108_CR5","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1093\/neuonc\/noab020","volume":"23","author":"RF Barajas","year":"2021","unstructured":"Barajas RF, Politi LS, Anzalone N et al (2021) Consensus recommendations for MRI and PET imaging of primary central nervous system lymphoma: guideline statement from the International Primary CNS Lymphoma Collaborative Group (IPCG). Neuro Oncol 23:1056\u20131071. https:\/\/doi.org\/10.1093\/neuonc\/noab020","journal-title":"Neuro Oncol"},{"key":"5108_CR6","doi-asserted-by":"publisher","first-page":"4643","DOI":"10.1200\/JCO.2002.11.013","volume":"20","author":"LM DeAngelis","year":"2002","unstructured":"DeAngelis LM, Seiferheld W, Schold SC et al (2002) Combination chemotherapy and radiotherapy for primary central nervous system lymphoma: Radiation Therapy Oncology Group study 93-10. J Clin Oncol 20:4643\u20134648. https:\/\/doi.org\/10.1200\/JCO.2002.11.013","journal-title":"J Clin Oncol"},{"key":"5108_CR7","doi-asserted-by":"publisher","first-page":"7860494","DOI":"10.1155\/2018\/7860494","volume":"2018","author":"Y Shan","year":"2018","unstructured":"Shan Y, Hu Y (2018) Prognostic factors and survival in primary central nervous system lymphoma: a population-based study. Dis Markers 2018:7860494. https:\/\/doi.org\/10.1155\/2018\/7860494","journal-title":"Dis Markers"},{"key":"5108_CR8","doi-asserted-by":"publisher","unstructured":"Abrey LE, Ben-Porat L, Panageas KS et al (2006) Primary central nervous system lymphoma: The Memorial Sloan-Kettering Cancer Center prognostic model. JCO 24:5711\u20135715. https:\/\/doi.org\/10.1200\/JCO.2006.08.2941","DOI":"10.1200\/JCO.2006.08.2941"},{"key":"5108_CR9","doi-asserted-by":"publisher","first-page":"e1027","DOI":"10.1212\/WNL.0000000000008900","volume":"94","author":"C Houillier","year":"2020","unstructured":"Houillier C, Soussain C, Ghesqui\u00e8res H et al (2020) Management and outcome of primary CNS lymphoma in the modern era. Neurology 94:e1027\u2013e1039. https:\/\/doi.org\/10.1212\/WNL.0000000000008900","journal-title":"Neurology"},{"key":"5108_CR10","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1093\/neuonc\/now033","volume":"18","author":"S Langner-Lemercier","year":"2016","unstructured":"Langner-Lemercier S, Houillier C, Soussain C et al (2016) Primary CNS lymphoma at first relapse\/progression: characteristics, management, and outcome of 256 patients from the French LOC network.\u00a0Neuro Oncol\u00a018:1297\u20131303. https:\/\/doi.org\/10.1093\/neuonc\/now033","journal-title":"Neuro-oncology"},{"key":"5108_CR11","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s11060-006-9165-6","volume":"80","author":"K Jahnke","year":"2006","unstructured":"Jahnke K, Thiel E, Martus P et al (2006) Relapse of primary central nervous system lymphoma: clinical features, outcome and prognostic factors. J Neurooncol 80:159\u2013165. https:\/\/doi.org\/10.1007\/s11060-006-9165-6","journal-title":"J Neurooncol"},{"key":"5108_CR12","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1002\/hon.944","volume":"29","author":"S Provencher","year":"2011","unstructured":"Provencher S, Ferlay C, Alaoui-Slimani K et al (2011) Clinical characteristics and outcome of isolated extracerebral relapses of primary central nervous system lymphoma: a case series. Hematol Oncol 29:10\u201316. https:\/\/doi.org\/10.1002\/hon.944","journal-title":"Hematol Oncol"},{"key":"5108_CR13","first-page":"9","volume":"4","author":"BD Cheson","year":"2015","unstructured":"Cheson BD (2015) Staging and response assessment in lymphomas: the new Lugano classification. Chinese Clinical Oncology 4:9","journal-title":"Chinese Clinical Oncology"},{"key":"5108_CR14","first-page":"1023","volume":"61","author":"SA Rosenberg","year":"1977","unstructured":"Rosenberg SA (1977) Validity of the Ann Arbor staging classification for the non-Hodgkin\u2019s lymphomas. Cancer Treat Rep 61:1023\u20131027","journal-title":"Cancer Treat Rep"},{"key":"5108_CR15","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1002\/ajh.23638","volume":"89","author":"JJ Castillo","year":"2014","unstructured":"Castillo JJ, Winer ES, Olszewski AJ (2014) Sites of extranodal involvement are prognostic in patients with diffuse large B-cell lymphoma in the rituximab era: an analysis of the Surveillance, Epidemiology and End Results database. Am J Hematol 89:310\u2013314. https:\/\/doi.org\/10.1002\/ajh.23638","journal-title":"Am J Hematol"},{"key":"5108_CR16","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1111\/bjh.14392","volume":"176","author":"R Kridel","year":"2017","unstructured":"Kridel R, Telio D, Villa D et al (2017) Diffuse large B-cell lymphoma with testicular involvement: outcome and risk of CNS relapse in the rituximab era.\u00a0Br J Haematol\u00a0176:210\u2013221. https:\/\/doi.org\/10.1111\/bjh.14392","journal-title":"British Journal of Haematology"},{"key":"5108_CR17","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1080\/1042819031000079195","volume":"44","author":"D Gholam","year":"2003","unstructured":"Gholam D, Bibeau F, El Weshi A et al (2003) Primary breast lymphoma. Leukemia & Lymphoma 44:1173\u20131178. https:\/\/doi.org\/10.1080\/1042819031000079195","journal-title":"Leukemia & Lymphoma"},{"key":"5108_CR18","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1182\/blood-2015-10-673236","volume":"127","author":"B Chapuy","year":"2016","unstructured":"Chapuy B, Roemer MGM, Stewart C et al (2016) Targetable genetic features of primary testicular and primary central nervous system lymphomas. Blood 127:869\u2013881. https:\/\/doi.org\/10.1182\/blood-2015-10-673236","journal-title":"Blood"},{"key":"5108_CR19","doi-asserted-by":"publisher","first-page":"5005","DOI":"10.1182\/blood-2009-12-258210","volume":"115","author":"S Grisariu","year":"2010","unstructured":"Grisariu S, Avni B, Batchelor TT et al (2010) Neurolymphomatosis: an International Primary CNS Lymphoma Collaborative Group report. Blood 115:5005\u20135011. https:\/\/doi.org\/10.1182\/blood-2009-12-258210","journal-title":"Blood"},{"key":"5108_CR20","doi-asserted-by":"publisher","first-page":"200","DOI":"10.4103\/sajc.sajc_65_18","volume":"7","author":"A Gogia","year":"2018","unstructured":"Gogia A, Das CK, Kumar L et al (2018) Diffuse large B-cell lymphoma: an institutional analysis. South Asian J Cancer 7:200\u2013202. https:\/\/doi.org\/10.4103\/sajc.sajc_65_18","journal-title":"South Asian J Cancer"},{"key":"5108_CR21","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1046\/j.1365-2141.2003.04749.x","volume":"124","author":"MB M\u00f8ller","year":"2004","unstructured":"M\u00f8ller MB, Pedersen NT, Christensen BE (2004) Diffuse large B-cell lymphoma: clinical implications of extranodal versus nodal presentation \u2013 a population-based study of 1575 cases.\u00a0Br J Haematol\u00a0124:151\u2013159. https:\/\/doi.org\/10.1046\/j.1365-2141.2003.04749.x","journal-title":"British Journal of Haematology"},{"key":"5108_CR22","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJM199309303291402","volume":"329","author":"International Non-Hodgkin\u2019s Lymphoma Prognostic Factors Project","year":"1993","unstructured":"International Non-Hodgkin\u2019s Lymphoma Prognostic Factors Project (1993) A predictive model for aggressive non-Hodgkin\u2019s lymphoma. N Engl J Med 329:987\u2013994. https:\/\/doi.org\/10.1056\/NEJM199309303291402","journal-title":"N Engl J Med"},{"key":"5108_CR23","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.2214\/AJR.20.24036","volume":"216","author":"HY Park","year":"2021","unstructured":"Park HY, Suh CH, Huang RY et al (2021) Diagnostic yield of body CT and whole-body FDG PET\/CT for initial systemic staging in patients with suspected primary CNS lymphoma: a systematic review and meta-analysis.\u00a0Am J Roentgenol\u00a0216:1172\u20131182. https:\/\/doi.org\/10.2214\/AJR.20.24036","journal-title":"American Journal of Roentgenology"},{"key":"5108_CR24","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1215\/15228517-2007-061","volume":"10","author":"NA Mohile","year":"2008","unstructured":"Mohile NA, DeAngelis LM, Abrey LE (2008) The utility of body FDG PET in staging primary central nervous system lymphoma. Neuro Oncol 10:223\u2013228. https:\/\/doi.org\/10.1215\/15228517-2007-061","journal-title":"Neuro Oncol"},{"key":"5108_CR25","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.clml.2021.03.011","volume":"21","author":"T Gupta","year":"2021","unstructured":"Gupta T, Manjali JJ, Kannan S et al (2021) Diagnostic performance of pretreatment 18F-fluorodeoxyglucose positron emission tomography with or without computed tomography in patients with primary central nervous system lymphoma: updated systematic review and diagnostic test accuracy meta-analyses. Clin Lymphoma Myeloma Leuk 21:497\u2013507. https:\/\/doi.org\/10.1016\/j.clml.2021.03.011","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"5108_CR26","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1007\/s00259-021-05603-w","volume":"49","author":"E Guedj","year":"2022","unstructured":"Guedj E, Varrone A, Boellaard R et al (2022) EANM procedure guidelines for brain PET imaging using [18F]FDG, version 3. Eur J Nucl Med Mol Imaging 49:632\u2013651. https:\/\/doi.org\/10.1007\/s00259-021-05603-w","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"5108_CR27","doi-asserted-by":"publisher","unstructured":"Jahnke K, Hummel M, Korfel A, et al (2006) Detection of subclinical systemic disease in primary CNS lymphoma by polymerase chain reaction of the rearranged immunoglobulin heavy-chain genes. JCO 24:4754\u20134757. https:\/\/doi.org\/10.1200\/JCO.2006.06.7165","DOI":"10.1200\/JCO.2006.06.7165"},{"key":"5108_CR28","doi-asserted-by":"publisher","first-page":"e388","DOI":"10.1016\/S2352-3026(16)30050-3","volume":"3","author":"G Illerhaus","year":"2016","unstructured":"Illerhaus G, Kasenda B, Ihorst G et al (2016) High-dose chemotherapy with autologous haemopoietic stem cell transplantation for newly diagnosed primary CNS lymphoma: a prospective, single-arm, phase 2 trial. The Lancet Haematology 3:e388\u2013e397. https:\/\/doi.org\/10.1016\/S2352-3026(16)30050-3","journal-title":"The Lancet Haematology"},{"key":"5108_CR29","doi-asserted-by":"publisher","unstructured":"Ferreri AJM, Blay J-Y, Reni M et al (2003) Prognostic scoring system for primary CNS lymphomas: the International Extranodal Lymphoma Study Group experience. JCO 21:266\u2013272. https:\/\/doi.org\/10.1200\/JCO.2003.09.139","DOI":"10.1200\/JCO.2003.09.139"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-023-05108-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-023-05108-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-023-05108-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,13]],"date-time":"2023-04-13T06:06:59Z","timestamp":1681366019000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-023-05108-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,29]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["5108"],"URL":"https:\/\/doi.org\/10.1007\/s00277-023-05108-6","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"value":"0939-5555","type":"print"},{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,29]]},"assertion":[{"value":"22 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}